Prognostic Impact of <scp><i>Clostridium butyricum</i> MIYAIRI</scp> (<scp>CBM588</scp>) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study

Authors

Institutions

Publication Details

Journal
Cancer Reports
Published
2025-08-01
DOI
https://doi.org/10.1002/cnr2.70308
Citations
1
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study

Akihiko Mitsuke, Satoru Inoguchi, Hirofumi Yoshino, Shuichi Tatarano et al.
1 citations
Cancer Reports
Bladder and Urothelial Cancer Treatments
2.01
article

Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study

Akihiko Mitsuke, Satoru Inoguchi, Hirofumi Yoshino, Shuichi Tatarano, Junya Arima, Hideki Enokida, Yasutoshi Yamada, Yoichi Osako, Ryosuke Matsushita, Takashi Sakaguchi
article en
1 citations

Abstract

No abstract available for this paper.
Cancer ReportsVol. 8(8)
Kagoshima University (JP)
Good health and well-being
Openalex Percentile: Top 13%
Bladder and Urothelial Cancer Treatments
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.